Given the pivotal roles of STK4 and IRAK1 in the production of proinflammatory cytokines and cell proliferation in liver tumor cells, targeting STK4 and IRAK1 may present a novel strategy for inhibiting the development of inflammation-related liver cancer. This evidence concerns the gene IRAK1 and liver cancer.